← Open Payments lookup

DIANA COZMA: Open Payments

NPI 1578860672 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,063 in 33 payments from 7 companies in 2025. Trend: 2023 $380 · 2024 $762 · 2025 $1,063

Food & beverage: $1,063
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$352
Teva Pharmaceuticals USA, Inc.7$206
Otsuka America Pharmaceutical, Inc.2$144
E.R. Squibb & Sons, L.L.C.2$126
Vanda Pharmaceuticals Inc.3$81
Janssen Pharmaceuticals, Inc4$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$74

Products named: INGREZZA, UZEDY, ABILIFY MAINTENA, COBENFY, FANAPT, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR.

Industry payments across PA — which companies pay providers there.